Fatty Acid-Binding Protein 4-An "Inauspicious" Adipokine-In Serum and Urine of Post-Partum Women with Excessive Gestational Weight Gain and Gestational Diabetes Mellitus.
Żaneta Kimber-TrojnarJolanta Patro-MałyszaMarcin TrojnarKatarzyna E Skórzyńska-DziduszkoJacek BartosiewiczJan OleszczukBożena Leszczyńska-GorzelakPublished in: Journal of clinical medicine (2018)
The exact roles of adipokines in the pathogenesis of type 2 diabetes and obesity are still unclear. The aim of the study was to evaluate fatty acid binding protein 4 (FABP4) concentrations in the serum and urine of women with excessive gestational weight gain (EGWG) and gestational diabetes mellitus (GDM) in the early post-partum period, with reference to their laboratory test results, body composition, and hydration status. The study subjects were divided into three groups: 24 healthy controls, 24 mothers with EGWG, and 22 GDM patients. Maternal body composition and hydration status were evaluated by the bioelectrical impedance analysis (BIA) method. Concentrations of FABP4, leptin, and ghrelin were determined via enzyme-linked immunosorbent assay (ELISA). Healthy women were characterized by the lowest serum leptin concentrations and by a negative correlation between the serum and urine FABP4 levels. Serum FABP4 levels were the highest in the GDM group. Serum FABP4 and leptin concentrations correlated positively in the GDM group. The EGWG group had the highest degree of BIA disturbances in the early puerperium and positive correlations between the urine FABP4 and serum leptin and ghrelin concentrations. The physiological and pathological significance of these findings requires further elucidation.
Keyphrases
- weight gain
- binding protein
- body composition
- birth weight
- body mass index
- fatty acid
- pregnancy outcomes
- resistance training
- pregnant women
- weight loss
- bone mineral density
- metabolic syndrome
- end stage renal disease
- computed tomography
- type diabetes
- ejection fraction
- skeletal muscle
- physical activity
- insulin resistance
- polycystic ovary syndrome
- chronic kidney disease
- prognostic factors
- molecular dynamics
- patient reported outcomes